Research and trials

We help researchers evaluate adherence (compliance) rates earlier and more accurately

Our flexible, asynchronous, video technology and person-to-person support scales the gold standard for medication adherence: Directly Observed Therapy.

Request a Demo

Low site burden,
increased cost efficiency

With low-friction patient onboarding, dedicated support, and active monitoring of real-time adherence data, we ensure a seamless experience for trial sites. This ultimately leads to more efficient trials and lower costs.

Remote confirmation of dose-by-dose adherence

We directly observe 100% of doses using asynchronous video technology. Our expert staff reviews patient-submitted videos to assess medication adherence—allowing for more accurate efficacy estimates and improved patient support.

Support for patient diversity

We have unique expertise helping historically underrepresented populations secure high rates of adherence. Our approach helps achieve enrollment diversity targets to maximize the generalizability of your results. Our platform supports 22 languages to enable the participation of diverse patients.
‍See our health equity statement.

An adherence platform that's easy to use, implement, and scale.

Patient App

Patients complete video check-ins of each dose, anytime and anywhere. The app is easy to use, convenient, and free to patients, offering:

  • Configurable medication reminders
  • Low-tech requirements (BYOD)
  • In-app messaging
  • Support for 22 Languages
  • Progress tracking
  • Human-centered design
  • Adherence metrics
  • Trial-specific resources
Web Portal

The care team portal is designed to guide study sites through medication observation and support, providing: 

  • Dose-by-dose medication assessment
  • Time and date-stamped submissions
  • Clinical escalation & alerts to relevant stakeholders
  • Robust adherence analytics
  • Video bank messaging 
  • Livestream video appointments
  • Missed submission alerts
  • Site support from our adherence review team
Analytics & Reporting

Reports include a specific breakdown of adherence-related challenges, including:

  • Real-time adherence analytics
  • Time and date stamped dosing
  • Administration technique issues
  • Side effects
  • Drug challenges
  • Behavioral challenges
  • Time trends
  • Social determinants of health (SDOH)

We’re clinically validated

25 peer-reviewed publications report high levels of adherence to treatment with our adherence platform.

Tuberculosis
95%
adherence
Partners:
Johns Hopkins, State of Maryland, NIH
transplant
90%
adherence
Partners:
Florida State University, University of Florida
Hepatitis C
98%
adherence among drug-using population
Partners:
University of Colorado Anschutz Medical Campus, Gilead-supported
asthma
81%
adoption
Published:
Journal of Asthma
TYPE 2 diabetes
83%
adherence
Medicaid Health Plan
Published results pending

[Scene's] customer service reps are much more friendly and knowledgeable about the system vs. another app that some studies use.”

Clinical Trial Manager, CRO

Peer reviewed study

2x
Participants were twice as likely to complete their doses compared to those using wirelessly observed therapy
98%
Median medication adherence among a drug-using cohort
In a drug trial with hepatitis C patients who inject drugs, researchers found that participants using Scene’s adherence platform had a higher adherence rate over an 84-dose regimen than those using a wireless pillbox technology.
Read study

Trusted by leading institutions

Schedule a time to connect with us

Our dose-by-dose adherence insights enable researchers to confirm compliance, accurately assess the benefits and harms of a medication, and reach and engage diverse populations. Schedule a time to connect with our growth team for a demo or to learn about partnership opportunities. We look forward to connecting with you!

Discover more